Cargando…

Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy

Cancer accounts for numerous deaths each year, and it is one of the most common causes of death worldwide, despite many breakthroughs in the discovery of novel anticancer candidates. Each new year the FDA approves the use of new drugs for cancer treatments. In the last years, the biological targets...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hawash, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776383/ https://www.ncbi.nlm.nih.gov/pubmed/36551271 http://dx.doi.org/10.3390/biom12121843

Ejemplares similares

Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site
por: Dong, Mengqi, et al.
Publicado: (2016)

Effect of Colchicine Binding Site Inhibitors on the Tubulin Intersubunit Interaction
por: Sargsyan, Arsen, et al.
Publicado: (2023)

The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site
por: Boichuk, Sergei, et al.
Publicado: (2021)

Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors
por: Sardaru, Monica-Cornelia, et al.
Publicado: (2020)

Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation
por: Liu, Wei, et al.
Publicado: (2023)

Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
por: Lu, Yan, et al.
Publicado: (2014)

Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin
por: Ma, Rundi, et al.
Publicado: (2007)

Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin
por: Sharma, Ashwani, et al.
Publicado: (2017)

Computational-Based Discovery of the Anti-Cancer Activities of Pyrrole-Based Compounds Targeting the Colchicine-Binding Site of Tubulin
por: Boichuk, Sergei, et al.
Publicado: (2022)

Optimization of 4-(N-Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine Site
por: Wang, Xiao-Feng, et al.
Publicado: (2014)

Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors
por: Fu, Dong-Jun, et al.
Publicado: (2020)

THE MECHANISM OF ACTION OF COLCHICINE : Colchicine Binding Properties of Sea Urchin Sperm Tail Outer Doublet Tubulin
por: Wilson, Leslie, et al.
Publicado: (1973)

Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
por: McLoughlin, Eavan C., et al.
Publicado: (2020)

Sustainable Syntheses of (−)-Jerantinines A & E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site
por: Smedley, Christopher J., et al.
Publicado: (2018)

Colchicine-binding activity distinguishes sea urchin egg and outer doublet tubulins
Publicado: (1984)

Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5(4H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site
por: El-Naggar, Abeer M., et al.
Publicado: (2020)

Consensus Virtual Screening Protocol Towards the Identification of Small Molecules Interacting with the Colchicine Binding Site of the Tubulin‐microtubule System
por: López‐López, Edgar, et al.
Publicado: (2022)

Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE
por: Nolasco, Sofia, et al.
Publicado: (2021)

Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistance.
por: Judson, I., et al.
Publicado: (1997)

Properties of tubulin in unfertilized sea urchin eggs. Quantitation and characterization by the colchicine-binding reaction
Publicado: (1976)

Modeling the Colchicum autumnale Tubulin and a Comparison of Its Interaction with Colchicine to Human Tubulin
por: Spasevska, Ivana, et al.
Publicado: (2017)

Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site
por: Wang, Guangcheng, et al.
Publicado: (2019)

Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site
por: Fu, Dong-Jun, et al.
Publicado: (2017)

New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure–activity relationships, and molecular modelling
por: Vicente-Blázquez, Alba, et al.
Publicado: (2021)

Interaction of Colchicine-Site Ligands With the Blood Cell-Specific Isotype of β-Tubulin—Notable Affinity for Benzimidazoles
por: Montecinos, Felipe, et al.
Publicado: (2022)

Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function
por: Lindamulage, I. Kalhari, et al.
Publicado: (2017)

Comprehensive Analysis of Binding Sites in Tubulin
por: Mühlethaler, Tobias, et al.
Publicado: (2021)

Design, synthesis and biological evaluation of tetrahydroquinoxaline sulfonamide derivatives as colchicine binding site inhibitors
por: Dong, Haiyang, et al.
Publicado: (2023)

Recent advancements in PARP inhibitors-based targeted cancer therapy
por: Zhou, Ping, et al.
Publicado: (2020)

Semisynthetic aurones inhibit tubulin polymerization at the colchicine-binding site and repress PC-3 tumor xenografts in nude mice and myc-induced T-ALL in zebrafish
por: Xie, Yanqi, et al.
Publicado: (2019)

Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors
por: Yao, Yongfang, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents
por: Majcher, Urszula, et al.
Publicado: (2018)

Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations
por: Tang, Sheng, et al.
Publicado: (2022)

Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
por: Chen, Hao, et al.
Publicado: (2017)

Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect
por: Yang, Jianhong, et al.
Publicado: (2021)

In silico study of colchicine resistance molecular mechanisms caused by tubulin structural polymorphism
por: Sahakyan, Harutyun, et al.
Publicado: (2019)

In silico Investigations of the Mode of Action of Novel Colchicine Derivatives Targeting β-Tubulin Isotypes: A Search for a Selective and Specific β-III Tubulin Ligand
por: Pallante, Lorenzo, et al.
Publicado: (2020)

N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity
por: Keenan, Bryce, et al.
Publicado: (2020)

Novel Colchicine Analogues Target Mitochondrial PT Pores Using Free Tubulins and Induce ROS-Mediated Apoptosis in Cancerous Lymphocytes
por: Aghvami, Marjan, et al.
Publicado: (2018)

A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization
por: Ebenezer, Oluwakemi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aeboss5qij06o08eulte10n2mo